Table of Contents Author Guidelines Submit a Manuscript
Journal of Addiction
Volume 2016, Article ID 1084235, 8 pages
http://dx.doi.org/10.1155/2016/1084235
Research Article

nor-BNI Antagonism of Kappa Opioid Agonist-Induced Reinstatement of Ethanol-Seeking Behavior

Department of Psychology, Grand Valley State University, Allendale, MI, USA

Received 12 August 2016; Accepted 10 October 2016

Academic Editor: Leandro F. Vendruscolo

Copyright © 2016 Erin Harshberger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. M. Walker, G. R. Valdez, J. P. McLaughlin, and G. Bakalkin, “Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence,” Alcohol, vol. 46, no. 4, pp. 359–370, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. F. I. Carroll, L. S. Harris, and M. D. Aceto, “Effects of JDTic, a selective κ-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model,” European Journal of Pharmacology, vol. 524, no. 1–3, pp. 89–94, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. L. Grella, D. Funk, K. Coen, Z. Li, and A. D. Lê, “Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats,” Behavioural Brain Research, vol. 265, pp. 188–197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Zhou, F. Leri, S. L. Grella, J. V. Aldrich, and M. J. Kreek, “Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats,” Synapse, vol. 67, no. 6, pp. 358–361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. G. R. Valdez, D. M. Platt, J. K. Rowlett, D. Ruedi-Bettschen, and R. D. Spealman, “Agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms,” Journal of Pharmacology and Experimental Therapeutics, vol. 232, no. 2, pp. 525–533, 2007. View at Google Scholar
  6. G. A. Deehan Jr., D. L. McKinzie, F. I. Carroll, W. J. McBride, and Z. A. Rodd, “The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats,” Pharmacology Biochemistry and Behavior, vol. 101, no. 4, pp. 581–587, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. R. Schank, A. L. Goldstein, K. E. Rowe et al., “The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety,” Addiction Biology, vol. 17, no. 3, pp. 634–647, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Funk, K. Coen, and A. D. Lê, “The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats,” Brain and Behavior, vol. 4, no. 3, pp. 356–367, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Endoh, H. Matsuura, C. Tanaka, and H. Nagase, “Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo,” Archives Internationales de Pharmacodynamie et de Therapie, vol. 316, pp. 30–42, 1992. View at Google Scholar
  10. I. Carroll, J. B. Thomas, L. A. Dykstra et al., “Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist,” European Journal of Pharmacology, vol. 501, no. 1–3, pp. 111–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Spanagel, O. F. X. Almeida, and T. S. Shippenberg, “Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes,” European Journal of Pharmacology, vol. 264, no. 2, pp. 157–162, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Takemori, B. Y. Ho, J. S. Naeseth, and P. S. Portoghese, “Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays,” Journal of Pharmacology and Experimental Therapeutics, vol. 246, no. 1, pp. 255–258, 1988. View at Google Scholar
  13. H. H. Samson, “Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats,” Alcoholism: Clinical and Experimental Research, vol. 10, no. 4, pp. 436–442, 1986. View at Publisher · View at Google Scholar · View at Scopus
  14. Z.-H. Zhu, B.-R. Wang, Q.-R. Tan et al., “Effect of water restrictions on the physiological parameters, psychological behavior and brain c-Fos expression in rat,” Neuroscience Bulletin, vol. 22, no. 3, pp. 144–150, 2006. View at Google Scholar · View at Scopus
  15. D. N. C. Jones and S. G. Holtzman, “Long term κ-opioid receptor blockade following nor-binaltorphimine,” European Journal of Pharmacology, vol. 215, no. 2-3, pp. 345–348, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. B. M. Walker and G. F. Koob, “Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence,” Neuropsychopharmacology, vol. 33, no. 3, pp. 643–652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. A. Nealey, A. W. Smith, S. M. Davis, D. G. Smith, and B. M. Walker, “κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats,” Neuropharmacology, vol. 61, no. 1-2, pp. 35–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. B. M. Walker, E. P. Zorrilla, and G. F. Koob, “Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats,” Addiction Biology, vol. 16, no. 1, pp. 116–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. R. Valdez and E. Harshberger, “Kappa opioid regulation of anxiety-like behavior during acute ethanol withdrawal,” Pharmacology Biochemistry and Behavior, vol. 102, no. 1, pp. 44–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. D. Lê, C. X. Poulos, S. Harding, J. Watchus, W. Juzytsch, and Y. Shaham, “Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress,” Neuropsychopharmacology, vol. 21, no. 3, pp. 435–444, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Burattini, T. M. Gill, G. Aicardi, and P. H. Janak, “The ethanol self-administration context as a reinstatement cue: acute effects of naltrexone,” Neuroscience, vol. 139, no. 3, pp. 877–887, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Bienkowski, W. Kostowski, and E. Koros, “Ethanol-reinforced behaviour in the rat: effects of naltrexone,” European Journal of Pharmacology, vol. 374, no. 3, pp. 321–327, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. K. R. Powell and S. G. Holtzman, “Differential antagonism of the rate-decreasing effects of κ-opioid receptor agonists by naltrexone and norbinaltorphimine,” European Journal of Pharmacology, vol. 377, no. 1, pp. 21–28, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. E. R. Butelman, M. C. Ko, K. Sobczyk-Kojiro et al., “Kappa-opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception,” Journal of Pharmacology and Experimental Therapeutics, vol. 285, no. 2, pp. 595–601, 1998. View at Google Scholar · View at Scopus
  25. K. A. Roth, E. Weber, J. D. Barchas, D. Chang, and J. K. Chang, “Immunoreactive dynorphin-(1–8) and corticotropin-releasing factor in subpopulation of hypothalamic neurons,” Science, vol. 219, no. 4581, pp. 189–191, 1983. View at Publisher · View at Google Scholar · View at Scopus
  26. B. A. S. Reyes, G. Drolet, and E. J. Van Bockstaele, “Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents,” Journal of Comparative Neurology, vol. 508, no. 4, pp. 663–675, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. R. Bruchas, B. B. Land, J. C. Lemos, and C. Chavkin, “CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior,” PLoS ONE, vol. 4, no. 12, Article ID e8528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. L. Laorden, M. T. Castells, M. D. Martínez, P. J. Martínez, and M. V. Milanés, “Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus,” Endocrinology, vol. 141, no. 4, pp. 1366–1376, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Ur, D. M. Wright, P. M. G. Bouloux, and A. Grossman, “The effects of spiradoline (U-62066E), a κ-opioid receptor agonist, on neuroendocrine function in man,” British Journal of Pharmacology, vol. 120, no. 5, pp. 781–784, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Vale, C. Rivier, M. R. Brown et al., “Chemical and biological characterization of corticotropin releasing factor,” Recent Progress in Hormone Research, vol. 39, pp. 245–270, 1983. View at Google Scholar · View at Scopus
  31. M. Kunihara, M. Ohyama, and M. Nakano, “Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective κ-opioid receptor agonist,” European Journal of Pharmacology, vol. 214, no. 2-3, pp. 111–118, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Jackisch, M. Geppert, and P. Illes, “Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit,” Journal of Neurochemistry, vol. 46, no. 6, pp. 1802–1810, 1986. View at Google Scholar · View at Scopus
  33. A. P. M. Cruz, F. Frei, and F. G. Graeff, “Ethopharmacological analysis of rat behavior on the elevated plus-maze,” Pharmacology, Biochemistry and Behavior, vol. 49, no. 1, pp. 171–176, 1994. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Gillett, E. Harshberger, and G. R. Valdez, “Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system,” Alcohol, vol. 47, no. 5, pp. 359–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Stevens Negus, “Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys,” Psychopharmacology, vol. 176, no. 2, pp. 204–213, 2004. View at Publisher · View at Google Scholar · View at Scopus